Odyssey Health (ODYY) Net Margin (2014 - 2016)

Odyssey Health (ODYY) posted quarterly Net Margin of 246.36% for Q3 2016, up 59.29% quarter-over-quarter from 605.12% in Q2 2016.

Odyssey Health (ODYY) Net Margin (2014 - 2016) Analysis & Trends

Odyssey Health's Net Margin history runs 3 years deep, the most recent figure standing at 246.36% for Q3 2016.

In Q3 2016, Net Margin changed N/A year-over-year to 246.36%; the TTM figure through Apr 2017 stood at 1136.24% (up 84407.0% YoY), while the FY2016 annual figure was 562.69%, down 46047.0% from the prior year.
Net Margin for Q3 2016 stood at 246.36%, up from 605.12% in the prior quarter.
The five-year high for Net Margin was 76.71% in Q4 2014, with the low at 605.12% in Q2 2016.
The 3-year median for Net Margin is 236.09% (2015), against an average of 259.35%.
Peak annual rise in Net Margin reached 36903 bps in 2016, while the deepest fall reached 36903 bps in 2016.
Odyssey Health's Net Margin stood at 76.71% in 2014, then slumped by 208 bps to 236.09% in 2015, then slipped by 4 bps to 246.36% in 2016.
Business Quant data shows ODYY's Net Margin at 246.36% in Q3 2016, 605.12% in Q2 2016, and 236.09% in Q2 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Abbott Laboratories	200.19 Bn	194.59 Bn	7.27 Bn	7.37%
2	Stryker	129.95 Bn	126.47 Bn	4.50 Bn	19.37%
3	Medtronic	120.06 Bn	110.84 Bn	6.41 Bn	12.84%
4	Boston Scientific	74.14 Bn	73.60 Bn	3.85 Bn	16.67%
5	Edwards Lifesciences	52.74 Bn	48.49 Bn	1.35 Bn	13.87%
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn	19.04%
7	GE HealthCare Technologies	34.20 Bn	32.10 Bn	2.18 Bn	10.84%
8	Koninklijke Philips	26.46 Bn	23.13 Bn	4.55 Bn	6.47%
9	Steris	23.25 Bn	22.77 Bn	684.20 Mn	13.47%
10	Odyssey Health	1.01 Mn	711,880.61	-	-

Download Data